TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 34 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $23,000 | +109.1% | 33,359 | +83.0% | 0.00% | 0.0% |
| Q4 2018 | $11,000 | -79.6% | 18,233 | -30.4% | 0.00% | -66.7% |
| Q3 2018 | $54,000 | +8.0% | 26,215 | +40.4% | 0.00% | +50.0% |
| Q2 2018 | $50,000 | -47.9% | 18,667 | -55.2% | 0.00% | -60.0% |
| Q1 2018 | $96,000 | +159.5% | 41,635 | +276.7% | 0.01% | +150.0% |
| Q4 2017 | $37,000 | -50.7% | 11,053 | -53.3% | 0.00% | -50.0% |
| Q3 2017 | $75,000 | – | 23,684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 995,000 | $3,134,000 | 0.33% |
| NEA Management Company, LLC | 2,759,217 | $8,692,000 | 0.30% |
| Eventide Asset Management | 900,000 | $2,835,000 | 0.16% |
| QVT Financial LP | 308,227 | $916,000 | 0.03% |
| Candriam S.C.A. | 143,000 | $450,000 | 0.01% |
| Virtu Financial LLC | 23,684 | $75,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 13,352 | $42,000 | 0.00% |
| BLUESTEIN R H & CO LLC | 16,000 | $50,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 54,135 | $171,000 | 0.00% |
| Alyeska Investment Group, L.P. | 97,676 | $308,000 | 0.00% |